Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.512
Bid: 1.50
Ask: 1.54
Change: -0.018 (-1.18%)
Spread: 0.04 (2.667%)
Open: 1.628
High: 1.628
Low: 1.478
Prev. Close: 1.53
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 1H2022 Condensed Separate Financial Results

25 Jul 2022 07:00

RNS Number : 5292T
Commercial Intnl Bank (Egypt) SAE
25 July 2022
 

 Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5292T_1-2022-7-24.pdf

Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

June 30, 2022

Condensed Separate Interim Balance Sheet as at June 30, 2022

 

Notes

Jun. 30, 2022

 

Dec. 31, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Assets

 

 

 

 

Cash and balances at the central bank

8

41,845,093

 

43,385,222

 

Due from banks

9

56,970,904

 

79,991,287

 

Loans and advances to banks, net

11

1,308,243

 

312,216

 

Loans and advances to customers, net

12

169,610,784

 

144,765,808

 

Derivative financial instruments

 

877,137

 

225,376

 

Investments

 

 

 

- Financial Assets at Fair Value through P&L

13

1,648

 

240,987

 

- Financial Assets at Fair Value through OCI

13

215,842,642

 

192,390,931

 

- Financial Assets at Amortized cost

13

19,723,117

 

20,318,767

 

- Investments in associates and subsidiaries

14

1,064,250

 

1,014,350

 

Other assets

15

11,626,924

 

11,141,917

 

Deferred tax assets (Liabilities)

 

354,638

 

460,026

 

Property and equipment

16

2,391,033

 

2,404,237

 

Total assets

 

521,616,413

 

496,651,124

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

17

2,969,822

 

862,759

 

Due to customers

18

427,556,083

 

406,100,916

 

Derivative financial instruments

 

34,934

 

265,265

 

Current income tax liabilities

2,330,166

 

2,234,985

 

Other liabilities

19

9,972,432

 

8,021,310

 

Issued debt instruments

20

1,864,924

 

1,557,263

 

Other loans

 

5,987,651

 

5,140,782

 

Other Provisions

21

5,355,635

 

3,539,676

 

Total liabilities

 

456,071,647

 

427,722,956

 

Equity

 

 

 

 

Issued and paid up capital

 

19,825,134

 

19,702,418

 

Reserves

36,022,139

 

33,767,423

 

Reserve for employee stock ownership plan (ESOP)

 

1,555,725

 

1,674,392

 

Retained earnings *

 

8,141,768

 

13,783,935

 

Total equity and net profit for the period / year

 

65,544,766

 

68,928,168

 

Total liabilities and equity

 

521,616,413

 

496,651,124

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

(Review report attached)

 

 

* Including net profit for the current period

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended June 30, 2022

 

 

 

 

Notes

 

 

Jun. 30, 2022

 

Jun. 30, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Interest and similar income

24,258,160

 

20,975,491

 

Interest and similar expense

(10,562,668)

 

(9,302,462)

 

Net interest income

13,695,492

 

11,673,029

 

 

 

 

 

Fee and commission income

2,408,556

 

1,798,447

 

Fee and commission expense

(1,072,802)

 

(687,129)

 

Net fee and commission income

1,335,754

 

1,111,318

 

 

 

 

 

Dividend income

 

62,799

 

63,572

 

Net trading income

5

 

1,013,504

 

274,657

 

Profits (Losses) on financial investments

13

 

1,065,443

 

577,519

 

Administrative expenses

 

(3,233,444)

 

(2,918,943)

 

Other operating (expenses) income

6

(2,509,857)

 

(1,113,292)

 

Impairment release (charges) for credit losses

 

 

(14,449)

 

(1,019,076)

 

Profit before income tax

 

11,415,242

 

8,648,784

 

 

 

 

 

Income tax expense

25

(3,110,536)

 

(2,590,270)

 

Deferred tax assets (Liabilities)

25

(530,715)

 

18,828

 

Net profit for the period

 

7,773,991

 

6,077,342

 

 

 

 

 

Earning per share

7

 

 

 

Basic

3.48

 

2.75

 

Diluted

3.44

 

2.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

CEO & Managing Director

 

Sherif Samy

 

Chairman

 

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended June 30, 2022

 

 

 

 

Jun. 30, 2022

 

Jun. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Net profit for the period

 

7,773,991

 

6,077,342

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income after income tax

(7,358,230)

 

(1,624,416)

 

Transferred from reserve on disposal of financial assets at fair value through OCI

(4,227)

 

(104,406)

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

104,188

 

(54,113)

 

Total comprehensive income for the period

515,722

 

4,294,407

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2022

 

 

Notes

Jun. 30, 2022

 

Jun. 30, 2021

EGP Thousands

 

EGP Thousands

 

 

Cash flow from operating activities

 

 

Profit before income tax

11,415,242

 

8,648,784

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

Fixed assets depreciation

 

16

427,873

 

411,612

Impairment charge for credit losses (Loans and advances to customers and banks)

 

 

(94,868)

 

1,060,008

Other provisions charges

 

21

1,513,984

 

350,323

Impairment charge for credit losses (due from banks)

 

 

5,357

 

13,181

Impairment (Released) charge for credit losses (financial investments)

103,960

 

(54,113)

Impairment (Released) charge for other assets

(277,768)

 

25,524

Exchange revaluation differences for financial assets at fair value through OCI and AC

(2,840,747)

 

50,039

Impairment (Released) charge financial assets at fair value through OCI

-

 

(72,957)

Utilization of other provisions

 

21

(1,707)

 

(44,173)

Other provisions no longer used

 

21

(267)

 

(9,145)

Exchange differences of other provisions

 

21

303,949

 

(9,196)

Losses (profits) from selling property and equipment

 

 

(1,142)

 

(1,250)

Losses (profits) from selling financial investments

 

13

(1,065,443)

 

(514,837)

Shares based payments

 

 

384,255

 

316,514

Impairment (Released) charges of investments in associates and subsidiaries

-

 

10,275

Operating losses (profits) before changes in operating assets and liabilities

9,872,678

 

10,180,589

 

 

 

Net decrease (increase) in assets and liabilities

 

 

Due from banks

13,240,715

 

(8,642,436)

Financial assets at fair value through P&L

 

13

239,339

 

151,530

Derivative financial instruments

 

 

(882,092)

 

(19,897)

Loans and advances to banks and customers

 

11 - 12

(25,746,135)

 

(12,680,083)

Other assets

 

 

(291,414)

 

(1,944,779)

Due to banks

 

17

2,107,063

 

(7,502,230)

Due to customers

 

18

21,455,167

 

44,869,003

Current income tax obligations paid

 

 

(780,370)

 

(973,779)

Other liabilities

 

 

(283,863)

 

794,030

Net cash used in (generated from) operating activities

 

 

18,931,088

 

24,231,948

 

 

 

Cash flow from investing activities

 

 

Proceeds (payments) for investment in associates.

(49,900)

 

(158,360)

Payment for purchases of property, equipment and branches constructions

(312,818)

 

(522,975)

Proceeds from selling property and equipment

1,142

 

1,250

Proceeds from redemption of financial assets at amortized cost

659,761

 

2,654,583

Payment for purchases of financial assets at amortized cost

(41,770)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI

(67,627,930)

 

(111,506,191)

Proceeds from selling financial assets at fair value through OCI

45,512,886

 

71,451,202

Net cash generated from (used in) investing activities

(21,858,629)

 

(38,084,335)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2022 (Cont.)

 

Jun. 30, 2022

 

Jun. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from financing activities

 

 

 

Increase (decrease) in long term loans

846,869

 

(2,120,154)

 

Dividend paid

(4,410,322)

 

(1,360,652)

 

Increase (decrease) in issued debt instruments

307,661

 

-

 

Capital increase

122,716

 

-

 

Net cash generated from (used in) financing activities

(3,133,076)

 

(3,480,806)

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

(6,060,617)

 

(17,333,193)

 

Beginning balance of cash and cash equivalent

60,891,899

 

75,965,247

 

Cash and cash equivalent at the end of the period

54,831,282

 

58,632,054

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

41,845,093

 

31,792,597

 

Due from banks

57,016,700

 

79,116,502

 

Treasury bills and other governmental notes

10

76,375,291

 

58,677,132

 

Obligatory reserve balance with CBE

 

(36,065,936)

 

(26,239,755)

 

Due from banks with maturities more than three months

(12,494,125)

 

(26,293,821)

 

Treasury bills with maturity more than three months

(71,845,741)

 

(58,420,601)

 

Total cash and cash equivalent

54,831,282

 

58,632,054

 

'

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2021

 

Jun. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Capital increase

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit of the year

-

-

-

-

-

-

-

6,077,342

-

6,077,342

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(1,624,416)

-

-

-

(1,624,416)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(54,113)

-

-

-

(54,113)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

316,514

316,514

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,188,052

9,141

6,367,810

1,381,162

62,767,634

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2022

 

 

 

Jun. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

EGP Thousands

 

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 

Capital increase

122,716

-

-

-

-

-

-

-

-

122,716

 

 

 

 

Transferred to reserves

-

670,872

8,836,326

-

2,947

-

-

(9,007,223)

(502,922)

-

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

 

 

 

 

Net profit of the year

-

-

-

-

-

-

-

7,773,991

-

7,773,991

 

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(4,227)

-

4,227

-

-

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

-

-

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(7,358,230)

-

-

-

(7,358,230)

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

104,188

-

-

-

104,188

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

384,255

384,255

 

 

 

 

Ending balance

19,825,134

3,963,946

37,096,858

1,549,445

18,947

(6,619,038)

11,981

8,141,768

1,555,725

65,544,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDRLUDDGDS
Date   Source Headline
22nd Feb 20227:00 amRNSCIB FY 2021 Consolidated Financial Results
22nd Feb 20227:00 amRNSCIB FY2021 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Separate Condensed Financial Results
12th Nov 20217:00 amRNSCIB 3Q21 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB1H2021 Earnings Release
13th Jul 20217:00 amRNSCIB1H2021 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB 1H2021 Condensed Separate Financial Results
24th Jun 20213:43 pmRNSRelease re the change of title of Mr.Hussein Abaza
24th May 20217:00 amRNSCIB 1Q2021 Earnings Release
24th May 20217:00 amRNSCIB 1st Quarter Consolidated Financial Results
24th May 20217:00 amRNSCIB 1st Quarter Separate Financial Results
29th Apr 202110:09 amRNSCIB FY2020 Annual Financial Report
31st Mar 20215:28 pmRNSResolutions of CIB ordinary GAM held on March 30
8th Mar 20218:24 amRNSInvitation to CIB OrdinaryGeneral Assembly Meeting
8th Mar 20217:00 amRNSRelease regarding a change in CIB's BOD Structure
1st Mar 20217:00 amRNSCIB FY20 Year End Earnings Release
1st Mar 20217:00 amRNSCIB FY20 Year End Separate Financial Results
1st Mar 20217:00 amRNSCIB FY20 Consolidated Results
16th Dec 20207:00 amRNSCIB 3Q20 Earnings Release
16th Dec 20207:00 amRNSCIB 3rd Quarter Consolidated Condensed Results
16th Dec 20207:00 amRNSCIB 3rd Quarter Separate Condensed Results
16th Nov 20207:00 amRNSCIB Release on November 15th,2020
27th Oct 20202:28 pmRNSCIB's Press Release dated October 27th, 2020
23rd Oct 20203:59 pmRNSCIB Press Release
12th Oct 20204:13 pmRNSRelease concerning changes in CIB'sBoard Structure
22nd Sep 20202:33 pmRNSRelease on change in Board of Directors Structure
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSCIB First Half 2020 Earnings Release
14th Jul 20207:00 amRNSCIB Consolidated Interim Condensed June Statements
14th Jul 20207:00 amRNSCIB Interim Separate Condensed June Statements
1st Jul 20201:04 pmRNSRelease on Subordinated debt from CDC
5th May 20207:00 amRNSCIB reports 1Q20 Earning Release
5th May 20207:00 amRNSCIB 1st Quarter Consolidated Results
5th May 20207:00 amRNSCIB 1st Quarter Separate Results
28th Apr 20207:00 amRNSCIB Year End 2019 IFRS Consolidated Results
27th Apr 20207:00 amRNSCIB acquires 51% of Mayfair Bank in Kenya
30th Mar 20209:00 amRNSRelease on CEO self-quarantine
24th Mar 202012:02 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSCIB's AGM Resolutions (March 15th 2020)
16th Mar 20207:00 amRNSCIB's EGM Resolutions (March 15th 2020)
20th Feb 20202:39 pmRNSItems to be discussed in EGM of March 15th, 2020
20th Feb 20202:37 pmRNSItems to be discussed in AGM of March 15th, 2020
18th Feb 20202:31 pmRNSInvitation to CIB Extraordinary GAM
18th Feb 20202:29 pmRNSInvitation toCIB Ordinary General Assembly Meeting
4th Feb 20207:00 amRNSFY 2019 Separate Financial Results
4th Feb 20207:00 amRNSFY 2019 Consolidated Financial Results
4th Feb 20207:00 amRNSFY 2019 Earnings Release
5th Nov 20197:00 amRNSCIB 3Q 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB Separate 3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.